Thilakarathne P

Johnson & Johnson Innovative Medicine EMEA, Paris, France.

1 paper

ArticleKetamine

Assessment of patient-reported depression severity in subpopulation of ESCAPE-TRD study: esketamine nasal spray versus quetiapine extended release for treatment-resistant depression.

Clemens K, Rive B, Joshi K +7